CytoReason, a trailblazer in computational disease models for biopharma R&D, has secured $80 million in a funding round led by OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific. This substantial investment marks a pivotal moment for CytoReason as it accelerates its mission to revolutionize pharmaceutical decision-making through advanced AI technology. The new funding will propel CytoReason’s…
In a significant advancement for operating theatre safety, Alesi Surgical, a pioneering UK surgical technology firm, has successfully raised £5 million in a funding round led by Mercia Ventures. This latest investment, which also includes participation from existing investors IP Group and Panakès Partners, will be instrumental in scaling the company’s innovative smoke management solutions….
In a landmark moment for Scotland’s burgeoning biotech scene, uFraction8, a trailblazing engineering firm based in Falkirk, has clinched a £3.4 million investment to propel its cutting-edge microfiltration technology onto the global stage. The funding round, spearheaded by the visionary Foresight Group, marks a resounding vote of confidence in uFraction8‘s mission to revolutionize bioprocessing with…
In a significant advancement for e-commerce optimization, Optiwise.ai has successfully secured $2.4 million in seed funding to enhance its revolutionary platform designed exclusively for sellers on Walmart Marketplace. This investment comes alongside the launch of Olivia, a cutting-edge GenAI-powered personal assistant tailored to assist both first-party suppliers and third-party sellers in maximizing their product listings…
The European Investment Bank (EIB) has announced a significant €20 million venture-debt financing deal with German medtech innovator Protembis. This funding is set to propel the development of Protembis’ cutting-edge ProtEmbo Cerebral Embolic Protection system, designed to safeguard patients’ brains during catheter-based heart procedures. Protembis, known for its trailblazing approach to medical technology, will utilize…
Steerlab, a Paris-based AI startup, has successfully raised €1.7 million in a pre-seed funding round, positioning itself to revolutionize the sales workflow automation landscape. The investment underscores a robust commitment to developing an advanced AI platform aimed at automating responses to Requests For Proposals (RFPs) and security questionnaires. This platform promises to enhance efficiency for…
Zhiyi Biotech, a pioneering clinical-stage biotech specializing in live biotherapeutic products (LBPs), has achieved significant milestones with its latest clinical trial results for SK10. The Phase I study, conducted in the United States, has demonstrated promising outcomes in the treatment of chemotherapy-induced diarrhea (CID) using SK10, an innovative heat-killed Bacteroides fragilis product. The randomized, double-blind,…
Foray Bioscience, a pioneering force in sustainable biotechnology, has announced a significant milestone with the successful closure of a $3 million seed funding round led by ReGen Ventures. This latest injection of capital, supported by prominent investors including The Engine Ventures and Susquehanna Sustainable Investments, underscores Foray’s commitment to reshaping the future of plant-based industries…
Seeq Corporation, a pioneering leader in industrial analytics and AI-driven monitoring, has successfully closed a $50 million Series D funding round. The round, spearheaded by global investment firm Sixth Street Growth, boosts Seeq’s total funding to approximately $165 million. Significant participation came from existing investors including Insight Partners, Altira Group, Second Avenue Partners, and Saudi…
For a biotech world often focused on oncology and gene editing, Hemab Therapeutics has carved out a very different frontier: rare, inherited bleeding disorders that have long gone overlooked. The company has raised $157 million in a Series C round, a multifold oversubscribed financing led by Sofinnova Partners, with participation from a global sovereign wealth…
